Results 201 to 210 of about 47,485 (252)
Some of the next articles are maybe not open access.
DeckerMed Psychiatry, 2018
The underlying pathophysiology of anxiety disorders revolve around neurotransmitter transmission, the pharmacologic target of common medication treatments. Pharmacologic treatment of anxiety disorders generally consists of benzodiazepines for short-term relief of anxiety symptoms and antidepressants as a long-term therapy. Benzodiazepines use should be
David A. Beck, Christine L. Beck
+4 more sources
The underlying pathophysiology of anxiety disorders revolve around neurotransmitter transmission, the pharmacologic target of common medication treatments. Pharmacologic treatment of anxiety disorders generally consists of benzodiazepines for short-term relief of anxiety symptoms and antidepressants as a long-term therapy. Benzodiazepines use should be
David A. Beck, Christine L. Beck
+4 more sources
Revue de l'infirmiere, 2008
Anxiety disorders may occur as primary conditions (generalized anxiety, panic disorder); or may be associated with other psychiatric syndromes such as major depression or dementia. Benzodiazepines are the most widely prescribed anxiolytics. However, antidepressants such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine ...
+6 more sources
Anxiety disorders may occur as primary conditions (generalized anxiety, panic disorder); or may be associated with other psychiatric syndromes such as major depression or dementia. Benzodiazepines are the most widely prescribed anxiolytics. However, antidepressants such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine ...
+6 more sources
Pharmacology Biochemistry and Behavior
Anxiety disorders are the most prevalent psychiatric pathology with substantial cost to society, but the existing treatments are often inadequate. This has rekindled the interest in the GABAA-receptor (GABAAR) positive allosteric modulator (PAM) compounds, which have a long history in treatment of anxiety beginning with diazepam, chlordiazepoxide, and ...
Rok, Cerne +3 more
openaire +2 more sources
Anxiety disorders are the most prevalent psychiatric pathology with substantial cost to society, but the existing treatments are often inadequate. This has rekindled the interest in the GABAA-receptor (GABAAR) positive allosteric modulator (PAM) compounds, which have a long history in treatment of anxiety beginning with diazepam, chlordiazepoxide, and ...
Rok, Cerne +3 more
openaire +2 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2012
Tsuyoshi, Okamura, Shuichi, Awata
openaire +3 more sources
Tsuyoshi, Okamura, Shuichi, Awata
openaire +3 more sources